AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.8888
-0.0896 (-9.16%)
At close: Apr 2, 2026, 4:00 PM EDT
0.9120
+0.0232 (2.61%)
After-hours: Apr 2, 2026, 8:00 PM EDT
AEON Biopharma Employees
AEON Biopharma had 5 employees as of December 31, 2024. The number of employees decreased by 5 or -50.00% compared to the previous year.
Employees
5
Change
-5
Growth
-50.00%
Revenue / Employee
n/a
Profits / Employee
-$7,844,400
Market Cap
22.49M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 5 | -5 | -50.00% |
| Jun 30, 2024 | 5 | -4 | -44.44% |
| Dec 31, 2023 | 10 | 2 | 25.00% |
| Jun 30, 2023 | 9 | 0 | - |
| Dec 31, 2022 | 8 | - | - |
| Sep 30, 2022 | 9 | 3 | 50.00% |
| Jun 30, 2021 | 6 | - | - |
| Mar 31, 2021 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Vistagen Therapeutics | 59 |
| Boundless Bio | 28 |
| Plus Therapeutics | 28 |
| Curis | 24 |
| Tempest Therapeutics | 21 |
| Outlook Therapeutics | 17 |
| Skye Bioscience | 12 |
| Cocrystal Pharma | 11 |
AEON News
- 3 hours ago - AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711 - GlobeNewsWire
- 3 hours ago - AEON Biopharma Receives Additional Notice Related to NYSE American Continued Listing Standards - GlobeNewsWire
- 4 days ago - AEON Biopharma Reports Full Year 2025 Financial Results and Highlights Positive Comparative Analytical Results and FDA Feedback for ABP-450 Biosimilar Program - GlobeNewsWire
- 2 months ago - AEON Biopharma Reports BPD Type 2a Meeting with FDA and Shareholder Approval of the November Transactions - GlobeNewsWire
- 3 months ago - AEON Biopharma Announces Execution of Exchange Agreement with Daewoong - GlobeNewsWire
- 4 months ago - AEON Biopharma Announces First Closing of PIPE Investment and Provides Update on FDA Type 2a Meeting Scheduling - GlobeNewsWire
- 5 months ago - AEON Biopharma Reports Third Quarter 2025 Results, Including Positive ABP-450 Biosimilarity Data and Strategic Positioning for Continued Growth - GlobeNewsWire
- 5 months ago - AEON Biopharma Announces Fundraise Totaling Up to ~$22 Million through Private Placement and Proposed Exchange of Daewoong Convertible Notes - GlobeNewsWire